Literature DB >> 26661525

Exosomal miRNAs in Heart Disease.

Claudio Iaconetti1, Sabato Sorrentino1, Salvatore De Rosa1, Ciro Indolfi2.   

Abstract

Micro-RNAs (miRNAs) are small noncoding RNAs involved in the posttranscriptional regulation of gene expression. Exosomes have recently emerged as novel elements of intercellular communication in the cardiovascular system. Exosomal miRNAs could be key players in intercellular cross-talk, particularly during different diseases such as myocardial infarction (MI) and heart failure (HF). This review addresses the functional role played by exosomal miRNAs in heart disease and their potential use as new biomarkers. ©2016 Int. Union Physiol. Sci./Am. Physiol. Soc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26661525     DOI: 10.1152/physiol.00029.2015

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  18 in total

Review 1.  Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma.

Authors:  Michela Bottani; Giuseppe Banfi; Giovanni Lombardi
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

2.  Effect on Intermittent Hypoxia on Plasma Exosomal Micro RNA Signature and Endothelial Function in Healthy Adults.

Authors:  Abdelnaby Khalyfa; Chunling Zhang; Ahamed A Khalyfa; Glen E Foster; Andrew E Beaudin; Jorge Andrade; Patrick J Hanly; Marc J Poulin; David Gozal
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

3.  CircMACF1 Attenuates Acute Myocardial Infarction Through miR-500b-5p-EMP1 Axis.

Authors:  Bo Zhao; Guangping Li; Jianjun Peng; Lihui Ren; Licheng Lei; Huiming Ye; Zuoyan Wang; Sheng Zhao
Journal:  J Cardiovasc Transl Res       Date:  2020-03-11       Impact factor: 4.132

Review 4.  Cardioprotection by remote ischemic conditioning and its signal transduction.

Authors:  Petra Kleinbongard; Andreas Skyschally; Gerd Heusch
Journal:  Pflugers Arch       Date:  2016-12-07       Impact factor: 3.657

Review 5.  New Insights into the Role of Exosomes in the Heart After Myocardial Infarction.

Authors:  Na Li; Luc Rochette; Yongxin Wu; Nathalie Rosenblatt-Velin
Journal:  J Cardiovasc Transl Res       Date:  2018-09-02       Impact factor: 4.132

6.  Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 7.  Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.

Authors:  Salvatore De Rosa; Biagio Arcidiacono; Eusebio Chiefari; Antonio Brunetti; Ciro Indolfi; Daniela P Foti
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-17       Impact factor: 5.555

8.  Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery.

Authors:  Sabato Sorrentino; Claudio Iaconetti; Salvatore De Rosa; Alberto Polimeni; Jolanda Sabatino; Clarice Gareri; Francesco Passafaro; Teresa Mancuso; Laura Tammè; Chiara Mignogna; Caterina Camastra; Giovanni Esposito; Antonio Curcio; Daniele Torella; Ciro Indolfi
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

9.  Plasma exosomes induced by remote ischaemic preconditioning attenuate myocardial ischaemia/reperfusion injury by transferring miR-24.

Authors:  Wen Minghua; Gong Zhijian; Huang Chahua; Liang Qiang; Xu Minxuan; Wang Luqiao; Zhang Weifang; Lu Peng; Zhan Biming; Yu Lingling; Wang Zhenzhen; Xu Jianqing; Bao Huihui; Wang Xiaozhong; Cheng Xiaoshu
Journal:  Cell Death Dis       Date:  2018-02-23       Impact factor: 8.469

Review 10.  The Potential Role of Platelet-Related microRNAs in the Development of Cardiovascular Events in High-Risk Populations, Including Diabetic Patients: A Review.

Authors:  Justyna Pordzik; Katarzyna Pisarz; Salvatore De Rosa; Axel Dyve Jones; Ceren Eyileten; Ciro Indolfi; Lukasz Malek; Marek Postula
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-20       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.